Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Bladder Neoplasms 40Carcinoma, Transitional Cell 3Muscle Invasive Bladder Cancer 2Infiltrating Bladder Urothelial Carcinoma 2Carcinoma, Renal Cell 2Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Diseases 1Ureteral Neoplasms 1Transitional Cell Carcinoma of the Bladder 1Transitional Cell Bladder Cancer 1Stage 0is Bladder Urothelial Carcinoma 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non-metastatic Muscle Invasive Bladder Cancer 1Invasive Bladder Cancer 1Ileus 1Cone Dystrophy 3 1Bladder Adenocarcinoma 1Adrenal Gland Neoplasms 1

Interventions

tislelizumab 2Cystectomy 2vistusertib 1toripalimab 1olaparib 1liposomal doxorubicin 1durvalumab 1disitamab vedotin 1danvatirsen 1adavosertib 1Surgical Procedures, Operative 1Rutin 1Radiation 1RC48 antibody 1Neoadjuvant Therapy 1Gemcitabine 1Cisplatin 1Chemoradiotherapy 1AZD4547 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Muscle Invasive Bladder Cancer × Cystectomy × Clear all
NCT07202819 2025-10-02

"NAC-MRI"

Assiut University

Phase NA Recruiting
76 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

NCT02716896 2019-11-25

Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer

The University of Texas Health Science Center at San Antonio

Phase NA Terminated
2 enrolled 8 charts
Genitourinary

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡